A ligand-independent VEGFR2 signaling pathway limits angiogenic responses in diabetes

Science Signaling

Volumn 7, Issue 307, 2014, Pages

  Warren, Carmen M ^a   Ziyad, Safiyyah ^a   Briot, Anaïs ^a   Der, Aaron ^a   Iruela Arispe, M Luisa ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; LIGAND; PROTEIN TYROSINE KINASE; REACTIVE OXYGEN METABOLITE; STREPTOZOCIN; VASCULOTROPIN RECEPTOR 2; GLUCOSE; SCAVENGER; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANTIOXIDANT ACTIVITY; ARTICLE; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; ENDOTHELIUM CELL; ENZYME ACTIVITY; GOLGI COMPLEX; HUMAN; HUMAN CELL; HYPERGLYCEMIA; IN VIVO STUDY; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; STREPTOZOTOCIN-INDUCED DIABETES MELLITUS; UMBILICAL VEIN ENDOTHELIAL CELL; ANIMAL; BLOOD VESSEL; CELL CULTURE; CELL MOTION; DOSE RESPONSE; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; GENETICS; IMMUNOBLOTTING; KNOCKOUT MOUSE; METABOLISM; MOUSE MUTANT; PATHOPHYSIOLOGY; PHOSPHORYLATION; PHYSIOLOGY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TRANSGENIC MOUSE; VASCULAR ENDOTHELIUM;

ACETYLCYSTEINE; ANIMALS; BLOOD VESSELS; CELL MOVEMENT; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOTHELIUM, VASCULAR; FREE RADICAL SCAVENGERS; GLUCOSE; GOLGI APPARATUS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IMMUNOBLOTTING; LIGANDS; MICE; MICE, KNOCKOUT; MICE, OBESE; MICE, TRANSGENIC; PHOSPHORYLATION; REACTIVE OXYGEN SPECIES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-2;

EID: 84892388917     PISSN: 19450877     EISSN: 19379145     Source Type: Journal    
DOI: 10.1126/scisignal.2004235     Document Type: Article

References (54)

1. C. C. L. Wang, J. E. B. Reusch, Diabetes and cardiovascular disease: Changing the focus from glycemic control to improving long-term survival. Am. J. Cardiol. 110, 58B-68B (2012).
2. A. Martin, M. R. Komada, D. C.Sane, Abnormal angiogenesis in diabetes mellitus. Med. Res. Rev. 23, 117-145 (2003).
3. U. Hink, H. Li, H. Mollnau, M. Oelze, E. Matheis, M. Hartmann, M. Skatchkov, F. Thaiss, R. A. Stahl, A. Warnholtz, T. Meinertz, K. Griendling, D. G. Harrison, U. Forstermann, T. Munzel, Mechanisms underlying endothelial dysfunction in diabetes mellitus. Circ. Res. 88, E14-E22 (2001).
4. C. Rask-Madsen, G. L. King, Vascular complications of diabetes: Mechanisms of injury and protective factors. Cell Metab. 17, 20-33 (2013).
5. F. Giacco, M. Brownlee, Oxidative stress and diabetic complications. Circ. Res. 107, 1058-1070 (2010).
6. P. Geraldes, G. L. King, Activation of protein kinase C isoforms and its impact on diabetic complications. Circ. Res. 106, 1319-1331 (2010).
7. A. Goldin, J. A. Beckman, A. M. Schmidt, M.A. Creager, Advanced glycation end products: Sparking the development of diabetic vascular injury. Circulation 114, 597-605 (2006).
8. T. Nishikawa, D. Edelstein, X. L. Du, S. Yamagishi, T. Matsumura, Y. Kaneda, M.A. Yorek, D. Beebe, P. J. Oates, H. P. Hammes, I. Giardino, M. Brownlee, Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404, 787-790 (2000).
9. M. Sundaresan, Z. X. Yu, V. J. Ferrans, K. Irani, T. Finkel, Requirement for generation of H2O2 for platelet-derived growth factor signal transduction. Science 270, 296-299 (1995).
10. Y. S. Bae, S. W. Kang, M. S. Seo, I. C. Baines, E. Tekle, P. B. Chock, S. G. Rhee, Epidermal growth factor (EGF)-induced generation of hydrogen peroxide. Role in EGF receptor-mediated tyrosine phosphorylation. J. Biol. Chem. 272, 217-221 (1997).
11. M. Ushio-Fukai, Y. Tang, T. Fukai, S. I. Dikalov, Y. Ma, M. Fujimoto, M. T. Quinn, P. J. Pagano, C. Johnson, R. W. Alexander, Novel role of gp91phox-containing NAD(P)H oxidase in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 91, 1160-1167 (2002).
12. N. Ferrara, Vascular endothelial growth factor: Basic science and clinical progress. Endocr. Rev. 25, 581-611 (2004).
13. C. M. Warren, M. L. Iruela-Arispe, Signaling circuitry in vascular morphogenesis. Curr. Opin. Hematol. 17, 213-218 (2010).
14. P. Carmeliet, V. Ferreira, G. Breier, S. Pollefeyt, L. Kieckens, M. Gertsenstein, M. Fahrig, A. Vandenhoeck, K. Harpal, C. Eberhardt, C. Declercq, J. Pawling, L. Moons, D. Collen, W. Risau, A. Nagy, Abnormal blood vessel development and lethality in embryos lacking a single VEGF allele. Nature 380, 435-439 (1996).
15. N. Ferrara, K. Carver-Moore, H. Chen, M. Dowd, L. Lu, K. S. O'Shea, L. Powell-Braxton, K. J. Hillan, M. W. Moore, Heterozygous embryonic lethality induced by targeted inactivation of the VEGF gene. Nature 380, 439-442 (1996).
16. F. Shalaby, J. Rossant, T. P. Yamaguchi, M. Gertsenstein, X. F. Wu, M. L. Breitman, A. C.Schuh, Failure of blood-island formation and vasculogenesis in Flk-1-deficient mice. Nature 376, 62-66 (1995).
17. R. L. Kendall, R. Z. Rutledge, X. Mao, A. J. Tebben, R. W. Hungate, K. A. Thomas, Vascular endothelial growth factor receptor KDR tyrosine kinase activity is increased by autophosphorylation of two activation loop tyrosine residueS.J. Biol. Chem. 274, 6453-6460 (1999).
18. E. Chou, I. Suzuma, K. J. Way, D. Opland, A. C. Clermont, K. Naruse, K. Suzuma, N. L. Bowling, C. J. Vlahos, L. P. Aiello, G. L. King, Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic states: A possible explanation for impaired collateral formation in cardiac tissue. Circulation 105, 373-379 (2002).
19. F. C.Sasso, D. Torella, O. Carbonara, G. M. Ellison, M. Torella, M. Scardone, C. Marra, R. Nasti, R. Marfella, D. Cozzolino, C. Indolfi, M. Cotrufo, R. Torella, T. Salvatore, Increased vascular endothelial growth factor expression but impaired vascular endothelial growth factor receptor signaling in the myocardium of type 2 diabetic patients with chronic coronary heart disease. J. Am. Coll. Cardiol. 46, 827-834 (2005).
20. P. Lindström, The physiology of obese-hyperglycemic mice [ob/ob mice]. Scientific World Journal 7, 666-685 (2007).
21. O. Seitz, C.Schürmann, N. Hermes, E. Müller, J. Pfeilschifter, S. Frank, I. Goren, Wound healing in mice with high-fat diet-or ob gene-induced diabetes-obesity syndromes: A comparative study. Exp. Diabetes Res. 2010, 476969 (2010).
22. S.Lee, T. T. Chen, C. L. Barber, M. C. Jordan, J. Murdock, S. Desai, N. Ferrara, A. Nagy, K. P. Roos, M. L. Iruela-Arispe, Autocrine VEGF signaling is required for vascular homeostasis. Cell 130, 691-703 (2007).
23. F. Galvagni, S. Pennacchini, A. Salameh, M. Rocchigiani, F. Neri, M. Orlandini, F. Petraglia, S. Gotta, G. L. Sardone, G. Matteucci, G. C. Terstappen, S. Oliviero, Endothelial cell adhesion to the extracellular matrix induces c-Src-dependent VEGFR-3 phosphorylation without the activation of the receptor intrinsic kinase activity. Circ. Res. 106, 1839-1848 (2010).
24. T. Tammela, G. Zarkada, H. Nurmi, L. Jakobsson, K. Heinolainen, D. Tvorogov,W. Zheng, C. A. Franco, A. Murtomäki, E. Aranda, N. Miura, S. Ylä-Herttuala, M. Fruttiger, T. Mäkinen, A. Eichmann, J.W. Pollard, H. Gerhardt, K. Alitalo, VEGFR-3 controls tip to stalk conversion at vessel fusion sites by reinforcing Notch signalling. Nat. Cell Biol. 13, 1202-1213 (2011).
25. S. Koch, S. Tugues, X. Li, L. Gualandi, L. Claesson-Welsh, Signal transduction by vascular endothelial growth factor receptors. Biochem. J. 437, 169-183 (2011).
26. A. Tiwari, J. J. Jung, S. M. Inamdar, D. Nihalani, A. Choudhury, The myosin motor Myo1c is required for VEGFR2 delivery to the cell surface and for angiogenic signaling. Am. J. Physiol. Heart Circ. Physiol. 304, H687-H696 (2013).
27. M. G. Lampugnani, F. Orsenigo, M. C. Gagliani, C. Tacchetti, E. Dejana, Vascular endothelial cadherin controls VEGFR-2 internalization and signaling from intracellular compartmentS.J. Cell Biol. 174, 593-604 (2006).
28. V. Manickam, A. Tiwari, J. J. Jung, R. Bhattacharya, A. Goel, D. Mukhopadhyay, A. Choudhury, Regulation of vascular endothelial growth factor receptor 2 trafficking and angiogenesis by Golgi localized t-SNARE syntaxin 6. Blood 117, 1425-1435 (2011).
29. Y. Okuno, A. Nakamura-Ishizu, K. Otsu, T. Suda, Y. Kubota, Pathological neoangiogenesis depends on oxidative stress regulation by ATM. Nat. Med. 18, 1208-1216 (2012).
30. A. Disanza, E. Frittoli, A. Palamidessi, G. Scita, Endocytosis and spatial restriction of cell signaling. Mol. Oncol. 3, 280-296 (2009).
31. A. A. Lanahan, K. Hermans, F. Claes, J. S. Kerley-Hamilton, Z. W. Zhuang, F. J. Giordano, P. Carmeliet, M. Simons, VEGF receptor 2 endocytic trafficking regulates arterial morphogenesis. Dev. Cell 18, 713-724 (2010).
32. D. Fulton, J. Fontana, G. Sowa, J. P. Gratton, M. Lin, K. X. Li, B. Michell, B. E. Kemp, D. Rodman, W. C.Sessa, Localization of endothelial nitric-oxide synthase phosphorylated on serine 1179 and nitric oxide in Golgi and plasma membrane defines the existence of two pools of active enzyme. J. Biol. Chem. 277, 4277-4284 (2002).
33. F. Bard, L. Mazelin, C. Péchoux-Longin, V. Malhotra, P. Jurdic, Src regulates Golgi structure and KDEL receptor-dependent retrograde transport to the endoplasmic reticulum. J. Biol. Chem. 278, 46601-46606 (2003).
34. R. van Haperen, C. Cheng, B. M. E. Mees, E. van Deel, M. deWaard, L. C. A. van Damme, T. van Gent, T. van Aken, R. Krams, D. J. Duncker, R. de Crom, Functional expression of endothelial nitric oxide synthase fused to green fluorescent protein in transgenic mice. Am. J. Pathol. 163, 1677-1686 (2003).
35. M. Hiyoshi, N. Takahashi-Makise, Y. Yoshidomi, N. Chutiwitoonchai, T. Chihara, M. Okada, N. Nakamura, S. Okada, S. Suzu, HIV-1 Nef perturbs the function, structure, and signaling of the Golgi through the Src kinase Hck. J. Cell. Physiol. 227, 1090-1097 (2012).
36. D. J. Gill, J. Chia, J. Senewiratne, F. Bard, Regulation of O-glycosylation through Golgito-ER relocation of initiation enzymeS.J. Cell Biol. 189, 843-858 (2010).
37. D. Matsuda, Y. Nakayama, S. Horimoto, T. Kuga, K. Ikeda, K. Kasahara, N. Yamaguchi, Involvement of Golgi-associated Lyn tyrosine kinase in the translocation of annexin II to the endoplasmic reticulum under oxidative stress. Exp. Cell Res. 312, 1205-1217 (2006).
38. Z. G. Jin, H. Ueba, T. Tanimoto, A. O. Lungu, M. D. Frame, B. C. Berk, Ligand-independent activation of vascular endothelial growth factor receptor 2 by fluid shear stress regulates activation of endothelial nitric oxide synthase. Circ. Res. 93, 354-363 (2003).
39. S. Filosto, E. M. Khan, E. Tognon, C. Becker, M. Ashfaq, T. Ravid, T. Goldkorn, EGF receptor exposed to oxidative stress acquires abnormal phosphorylation and aberrant activated conformation that impairs canonical dimerization. PLOS One 6, e23240 (2011).
40. S. Ikeda, M. Ushio-Fukai, L. Zuo, T. Tojo, S. Dikalov, N. A. Patrushev, R. W. Alexander, Novel role of ARF6 in vascular endothelial growth factor-induced signaling and angiogenesis. Circ. Res. 96, 467-475 (2005).
41. J. Oshikawa, N. Urao, H. W. Kim, N. Kaplan, M. Razvi, R. McKinney, L. B. Poole, T. Fukai, M. Ushio-Fukai, Extracellular SOD-derived H2O2 promotes VEGF signaling in caveolae/ lipid rafts and post-ischemic angiogenesis in mice. PLOS One 5, e10189 (2010).
42. M. Lee, W. C. Choy, M. R. Abid, Direct sensing of endothelial oxidants by vascular endothelial growth factor receptor-2 and c-Src. PLOS One 6, e28454 (2011).
43. D. H. Kang, D. J. Lee, K. W. Lee, Y. S. Park, J. Y. Lee, S. H. Lee, Y. J. Koh, G. Y. Koh, C. Choi, D. Y. Yu, J. Kim, S. W. Kang, Peroxiredoxin II is an essential antioxidant enzyme that prevents the oxidative inactivation of VEGF receptor-2 in vascular endothelial cells. Mol. Cell 44, 545-558 (2011).
44. S.Lee, S. M. Jilani, G. V. Nikolova, D. Carpizo, M. L. Iruela-Arispe, Processing of VEGF-A by matrix metalloproteinases regulates bioavailability and vascular patterning in tumorS.J. Cell Biol. 169, 681-691 (2005).
45. H. Kawamura, X. Li, K. Goishi, L. A. van Meeteren, L. Jakobsson, S. Cébe-Suarez, A. Shimizu, D. Edholm, K. Ballmer-Hofer, L. Kjellén, M. Klagsbrun, L. Claesson-Welsh, Neuropilin-1 in regulation of VEGF-induced activation of p38MAPK and endothelial cell organization. Blood 112, 3638-3649 (2008).
46. S. D. Robinson, L. E. Reynolds, V. Kostourou, A. R. Reynolds, R. G. da Silva, B. Tavora, M. Baker, J. F. Marshall, K. M. Hodivala-Dilke, avb3 Integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesiS.J. Biol. Chem. 284, 33966-33981 (2009).
47. T. T. Chen, A. Luque, S.Lee, S. M. Anderson, T. Segura, M. L. Iruela-Arispe, Anchorage of VEGF to the extracellular matrix conveys differential signaling responses to endothelial cellS.J. Cell Biol. 188, 595-609 (2010).
48. Y. Zhang, R. Proenca, M. Maffei, M. Barone, L. Leopold, J. M. Friedman, Positional cloning of the mouse obese gene and its human homologue. Nature 372, 425-432 (1994).
49. J. A. Alva, A. C. Zovein, A. Monvoisin, T. Murphy, A. Salazar, N. L. Harvey, P. Carmeliet, M. L. Iruela-Arispe, VE-Cadherin-Cre-recombinase transgenic mouse: A tool for lineage analysis and gene deletion in endothelial cells. Dev. Dyn. 235, 759-767 (2006).
50. H. P. Gerber, K. J. Hillan, A. M. Ryan, J. Kowalski, G. A. Keller, L. Rangell, B. D. Wright, F. Radtke, M. Aguet, N. Ferrara, VEGF is required for growth and survival in neonatal mice. Development 126, 1149-1159 (1999).
51. P. Soriano, C. Montgomery, R. Geske, A. Bradley, Targeted disruption of the c-src proto-oncogene leads to osteopetrosis in mice. Cell 64, 693-702 (1991).
52. M. W. Appleby, J. A. Gross, M. P. Cooke, S. D. Levin, X. Qian, R. M. Perlmutter, Defective T cell receptor signaling in mice lacking the thymic isoform of p59fyn. Cell 70, 751-763 (1992).
53. E. Zudaire, L. Gambardella, C. Kurcz, S. Vermeren, C. Ruhrberg, A computational tool for quantitative analysis of vascular networks. PLOS One 6, e27385 (2011).
54. J. N. Rybak,A.Ettorre,B.Kaissling,R.Giavazzi,D.Neri,G.Elia, In vivo protein biotinylation for identification of organ-specific antigens accessible from the vasculature. Nat. Methods 2, 291-298 (2005).